FINancial Toxicity and CAncer REcovery in YOUNG Adults
This study, called FINCARE-Young, is looking into how much cancer and its treatment affect the finances of young adults. It wants to understand the money worries and costs that people aged 18 to 39 face while they are having cancer treatment and after it finishes. Researchers will explore how these financial burdens change over time and what factors might be making them worse. They also want to see how these financial difficulties impact a young person's ability to work and get back to their normal social life. By focusing on this group, the study hopes to find better ways to support young cancer survivors and help reduce the money problems they might experience in the long run.
At a glance
What is this study about?
This study is called FINCARE-Young, and its main goal is to understand the financial impact of cancer on young adults. We know that facing cancer is incredibly tough, and it can also bring unexpected financial worries, sometimes called 'financial toxicity'. This study will look at how much of a financial burden young people between the ages of 18 and 39 experience when they are going through cancer treatment and also after their treatment has finished. Researchers want to see if these financial difficulties get better or worse over time.
The study also aims to figure out what kinds of things might lead to these financial problems. For example, they'll look at a person's background, their specific cancer, and their economic situation. Importantly, they'll also explore how these money worries affect everyday life, such as finding a job or getting back to social activities after cancer.
By focusing on young adults, this research will fill an important gap in our understanding. The information gathered from this study could help healthcare teams and support organisations develop better ways to help young cancer survivors cope with the financial side effects of their illness and improve their long-term well-being.
Key takeaways
- This study explores the financial challenges faced by young adults with cancer.
- It aims to understand money worries during and after cancer treatment.
- Participation involves sharing experiences through interviews and questionnaires.
- The study focuses on patients treated at the University Medical Center Göttingen.
- Your involvement could help improve support for future cancer patients.
- You won't receive new treatments or medicines in this study.
Who may be eligible?
To join this study, you need to be a young adult who was diagnosed with cancer when you were between 18 and 39 years old. You must have received your cancer treatment at the University Medical Center Göttingen in Germany, and your main cancer treatment must have finished by the time you join the study. Your cancer diagnosis should have been between 2014 and 2024.
It's important that you are able to understand what the study involves and agree to take part. You also need to be able to speak and understand German well enough to have a phone interview and fill out questionnaires. The study is open to both men and women.
You cannot join if you were under 18 or over 39 when you were first diagnosed with cancer, or if you are still having active main cancer treatment. Also, if you have severe memory problems or a mental health condition that would make it hard to take part reliably, or if your German language skills aren't sufficient, you wouldn't be able to participate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Were you between 18 and 39 years old when you were first diagnosed with cancer?
- Did you receive your cancer treatment at the University Medical Center Göttingen?
- Has your main cancer treatment finished by now?
- Were you diagnosed between 2014 and 2024?
- Can you speak and understand German well enough for interviews and questionnaires?
- Are you able to agree to take part in the study?
What does participation involve?
Taking part in this study would involve answering questions about your financial situation, employment, and social life. This would likely be through a telephone interview and by filling out some questionnaires. You won't be given any new medications or treatments as part of this study. The study looks at your experiences following your cancer treatment, so there wouldn't be any physical visits for medical assessment related to the study. The total duration of your involvement would depend on how many times they ask you to complete questionnaires or interviews over time, but it focuses on your financial situation after your main cancer treatment has ended. Specific details about the number of interviews/questionnaires and their timings would be explained fully if you decide to consider joining.
Potential risks and benefits
Locations (1)
- University Medicine GöttingenVerified postcodeGöttingen, Germany
Common questions
What does 'financial toxicity' mean?
It means the financial problems and burdens that people face because of their cancer diagnosis and treatment, like unexpected costs or loss of income.
Do I need to be currently having cancer treatment to join?
No, you must have finished your main cancer treatment by the time you join the study.
Will I be given any new medicine or treatment?
No, this study is about understanding experiences through interviews and questionnaires, not about new treatments.
Where does the study take place?
The study focuses on patients treated at the University Medical Center Göttingen in Germany, and involves telephone interviews and questionnaires.
Can I stop participating in the study if I change my mind?
Yes, you can withdraw from the study at any time without needing to give a reason, and it won't affect your medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.